TARPLIN, DOWNS & YOUNG, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
**see addendum page budget resolution, reconciliation, health care reform, deficit reduction H.Con.Res. 112, budget resolution for 2013 H.R. 5872, Sequestration Transparency Act of 2012 H.R. 8, American Taxpayer Relief Act of 2012
Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."1
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Health Issues HCR
**see addendum page S. 660 - PATIENTS Act of 2011, comparative effectiveness S. 296/H.R. 2245 - Preserving Access to Life Saving Medications Act Health care reform, drug importation, 340b, biosimilars PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***no specific bills, importation, Prescription Drug User Fee Act Renewal and associated policies, supply chain integrity
Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Medicare/Medicaid MMM
**see addendum page PL 111-148 - The Patient Protection and Affordable Care Act, implementation, ESRD, clinical laboratory payment S. 668 - Health Care Bureaucrats Elimination Act, IPAB H.R. 452 Medicare Decisions Accountability Act of 2011 (IPAB) H.R. 5 - Protecting Access to Healthcare Act H.R. 8 - American Taxpayer Relief Act of 2012, ESRD ***, no specific bill(s), implementation of QIP and MIPPA ESRD bundling provisions, Medicare Reimbursement, Medicaid Rebate, Medicaid reimbursement, quality indicators, deficit reduction
Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. On Finance; |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | Congressman Billy Tauzin |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.